Affected by the domestic procurement policy of medical devices, the company's income from trauma or spine was 65.438+0.5 billion, down 654.38+0.4% year-on-year. However, the sales of medical devices increased by 60% year-on-year, which is obviously not increasing profits. At the same time, the profit of subsidiary Adil decreased, resulting in its goodwill impairment of 654.38+0.5 billion. In the past two years, the epidemic situation has been repeated, so the medical device trade of Kailitai has also been affected, which is 30% lower than last year.
Kailitai was founded in 2005. At the beginning of its establishment, the company was mainly engaged in the research and development, production and sales of orthopedic implants, and was the main supplier of minimally invasive surgery products for vertebroplasty. The company landed on GEM on 20 12.